Physician profile
Frank Ma
NPI 1851972442
$1,322.64
in general payments reported to CMS, 2019-2025
9 companies · $544 in 2025
The $544 reported for 2025 was more than what 91% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $779 · 2025: $544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,322.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $340.42 | 2024-2025 | Ngenuity, Clareon Panoptix Pro |
| Shockwave Medical, INC | $227.59 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Apellis Pharmaceuticals, INC. | $221.38 | 2025 | Syfovre |
| Dutch Ophthalmic, USA | $164.80 | 2024 | Tissueblue, Eva, Combined Machine |
| Penumbra, INC. | $148.75 | 2024 | Indigo System |
| Regeneron Pharmaceuticals, INC. | $113.12 | 2025 | Eylea Hd, Eylea |
| Alimera Sciences, INC. | $47.32 | 2024 | Iluvien, Yutiq |
| E.R. Squibb & Sons, L.L.C. | $46.75 | 2024 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.51 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.